Double‐unit unrelated cord blood transplantation for thalassemia major: Comparison with HLA‐identical sibling bone marrow transplantation-Reference-Cited by-同舟云学术

Double‐unit unrelated cord blood transplantation for thalassemia major: Comparison with HLA‐identical sibling bone marrow transplantation

Published:2020-11-02 Issue:3 Volume:25 Page:
ISSN:1397-3142
Container-title:Pediatric Transplantation
language:en
Short-container-title:Pediatr Transplant

Author:

Feng Jianhua¹²^ORCID,Lee Vincent³,Leung Alex W. K.¹,Lam Grace K. S.³,Chow Terry T. W.³,Cheng Frankie W. T.³,Yan Carol L. S.³,Lee Cheuk Kwong⁴,Yuen Patrick M. P.¹,Li Chi Kong¹³⁵^ORCID

Affiliation:

1. Department of Paediatrics The Chinese University of Hong Kong Hong Kong Hong Kong SAR

2. Department of Paediatrics The First Affiliated Hospital of Wenzhou Medical University Wenzhou China

3. Department of Paediatrics and Adolescent Medicine Hong Kong Children’s Hospital New Territories Hong Kong SAR

4. Red Cross Blood Transfusion Service Hospital Authority Hong Kong Cord Blood Bank New Territories Hong Kong SAR

5. Hong Kong Hub of Paediatric Excellence The Chinese University of Hong Kong Hong Kong Hong Kong SAR

Publisher

Wiley

Subject

Transplantation,Pediatrics, Perinatology, and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/petr.13901

Reference32 articles.

1. Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel

2. Bone Marrow Transplantation in Patients with Thalassemia

3. HLA Compatibility for patients with thalassemia: Implications for bone marrow transplantation

5. A novel conditioning regimen improves outcomes in β-thalassemia major patients using unrelated donor peripheral blood stem cell transplantation

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thalassaemia in China;Blood Reviews;2023-07

2. Curative therapy for hemoglobinopathies: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee review comparing outcomes, accessibility and cost of ex vivo stem cell gene therapy versus allogeneic hematopoietic stem cell transplantation;Cytotherapy;2021-12

3. Improving outcomes and quality of life for patients with transfusion-dependent β-thalassemia: recommendations for best clinical practice and the use of novel treatment strategies;Expert Review of Hematology;2021-09-15